2018 trading update: strong growth in Audit & Inspection
IMPORTANT DISCLOSURE: This research has been commissioned and paid for by the company and is deemed to constitute an acceptable minor non-monetary benefit as defined in MiFID II.


2018 trading update: strong growth in Audit & Inspection

Trading update from Dietswell : FY18 revenues are up 4% yoy, driven by a strong H2 in the Factorig division (Audit & Inspection).

FY18 revenues: €7.1m (+4 % yoy)

  • Factorig (Audit & Inspection): €4.2m (+61% yoy)
  • Services (Technical Assistance): €2.7m (-34% yoy)
  • Solutions (Engineering): €0.2m (€0.1m FY17)

The key pieces from this release are the confirmation of the recovery and the resilience of the oil & gas activities. Despite the oil price slide seen in Q4, the group has recorded a strong H2 (+45% vs H1) and beats our estimate of FY18 revenues of €7.1m (estimated : €6.5m). Growth is coming from the Factorig division (Audit & Inspection), with revenues accelerating fast (i.e. Q4 18 revenues of €1.5m against H1 18 of €1.54m), due to the restart of drilling activity worldwide (i.e. international rig count is up c.9% yoy).

In New Energies, Dolfines has recorded an engineering contract for an offshore installation attached to a wind farm.

With Brent back up above $60/bbl, we remain confident on the recovery of the engineering services in oil & gas. Maintained drilling activity should benefit Dietswell, supported by the renewal of the API Q2 certification announced in January. FY results are scheduled for the 26 April (after market) and will provide details on profitability and margins.

View all research reports on Dietswell: cliquez-ici

view detailed fundemental analysis on Dietswell : cliquez-ici

The AlphaValue Corporate Services analysts are AlphaValue’s sector specialists. Their robust knowledge of the business models in their sectors enables the rapid generation of incisive, relevant research and advantageous interaction with the management teams.

IMPORTANT DISCLOSURES: COPYRIGHT 2019, AlphaValue. All rights reserved. Contract research, paid for by the above corporate entity. Equity research methods and procedures are as applied by AlphaValue. Target prices and opinions are thus exclusively determined by those methods and procedures. All opinions and estimates included herein represent the personal, technical judgment of the analyst as of the date of this report and are subject to change without prior notice. The information contained herein is not intended to be an offer/solicitation to buy or sell any securities and has been compiled from sources believed to be reliable, but while all reasonable care has been taken to ensure that the information contained herein is not untrue or misleading at the time of publication, we make no representation that it is accurate or complete and it should not be relied upon as such. AlphaValue does not accept any liability whatsoever for any direct or consequential loss arising from any use of this report or its contents, including the investment view held in this report.

Related posts